Arkolith/Insider Trading/PHGE/Form 4

Oron Assaf

Chief Business OfficerBiomX Inc. (PHGE) · full profile →Form 4 · filed Dec 13, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 11, 2023Grant(A)9K——9K
Dec 11, 2023Disposed to issuer(D)33K——0
Dec 11, 2023Grant(A)8K——8K
Dec 11, 2023Disposed to issuer(D)32K——0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-095415) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML